CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration

Ophthalmology

Volumn 120, Issue 11, 2013, Pages 2317-2323

  Awh, Carl C ^a   Lane, Anne Marie ^b   Hawken, Steven ^c   Zanke, Brent ^c,d   Kim, Ivana K ^b  

^a Tennessee Retina   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d Arctic Group of Companies   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; COMPLEMENT FACTOR H; COPPER; DNA; PLACEBO; ZINC OXIDE;

AGE RELATED MACULOPATHY SENSITIVITY 2; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DISEASE COURSE; DNA POLYMORPHISM; GENE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT RESPONSE;

AGED; ALLELES; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; COMPLEMENT FACTOR H; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PROTEINS; RISK FACTORS; VITAMIN E; VITAMINS; ZINC COMPOUNDS;

EID: 84887210076     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.07.039     Document Type: Article

References (27)

1. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of highdose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 Arch Ophthalmol 119 2001 1417 1436
2. R. Nan, J. Gor, I. Lengyel, and S.J. Perkins Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease J Mol Biol 384 2008 1341 1352
3. S.J. Perkins, R. Nan, and K. Li Complement factor H-ligand interactions: self-association, multivalency and dissociation constants Immunobiology 217 2012 281 297
4. R. Nan, I. Farabella, and F.F. Schumacher Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration J Mol Biol 408 2011 714 735
5. P.C. Calder, R. Albers, and J.M. Antoine Inflammatory disease processes and interactions with nutrition Br J Nutr 101 suppl 2009 S1 45
6. L.G. Fritsche, T. Loenhardt, and A. Janssen Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA Nat Genet 40 2008 892 896
7. A. Zambon, S.S. Deeb, and P. Pauletto Hepatic lipase: a marker for cardiovascular disease risk and response to therapy Curr Opin Lipidol 14 2003 179 189
8. W. Wang, S.L. Connor, and E.J. Johnson Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration Am J Clin Nutr 85 2007 762 769
9. K.J. Meyers, E.J. Johnson, and P.S. Bernstein Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study Invest Ophthalmol Vis Sci 54 2013 2333 2345
10. J.M. Seddon, U.A. Ajani, and R.D. Sperduto Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration JAMA 272 1994 1413 1420
11. Y. Yu, R. Reynolds, and B. Rosner Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models Invest Ophthalmol Vis Sci 53 2012 1548 1556
12. M. Li, P. Atmaca-Sonmez, and M. Othman CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration Nat Genet 38 2006 1049 1054
13. J.H. Zar Biostatistical Analysis 4th ed. 1999 Prentice Hall Upper Saddle River, NJ 132 140
14. Abdi H. Bonferroni test. In: Salkind, NJ, ed. Encyclopedia of Measurement and Statistics. vol. 1. Thousand Oaks, CA: Sage; 2007:103-107.
15. Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration: AREDS report no. 18 Arch Ophthalmol 123 2005 1570 1574
16. E.Y. Chew, T.E. Clemons, and E. Agron Age-Related Eye Disease Study Research Group Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 Ophthalmology 120 2013 1604 1611
17. M.L. Klein, P.J. Francis, and B. Rosner CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration Ophthalmology 115 2008 1019 1025
18. S.J. Perkins, A.S. Nealis, and R.B. Sim Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering Biochemistry 30 1991 2847 2857
19. A.I. Okemefuna, R. Nan, and A. Miller Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations J Biol Chem 285 2010 1053 1065
20. B. Bao, A.S. Prasad, and F.W. Beck Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent Am J Clin Nutr 91 2010 1634 1641
21. D.C. Wallace A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine Annu Rev Genet 39 2005 359 407
22. M.J. Barron, M.A. Johnson, and R.M. Andrews Mitochondrial abnormalities in ageing macular photoreceptors Invest Ophthalmol Vis Sci 42 2001 3016 3022
23. G. Kroemer, and J.C. Reed Mitochondrial control of cell death Nat Med 6 2000 513 519
24. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
25. S. Beatty, H. Koh, and M. Phil The role of oxidative stress in the pathogenesis of age-related macular degeneration Surv Ophthalmol 45 2000 115 134
26. H.M. McBride, M. Neuspiel, and S. Wasiak Mitochondria: more than just a powerhouse Curr Biol 16 2006 R551 R560
27. Age-Related Eye Disease Study 2 (AREDS2) Research Group Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4 JAMA Ophthalmol 131 2013 843 850